KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) FCF Margin: 2010-2024

Historic FCF Margin for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Dec 2024 value amounting to 25.87%.

  • Supernus Pharmaceuticals' FCF Margin fell 6252.00% to -32.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.38%, marking a year-over-year decrease of 1600.00%. This contributed to the annual value of 25.87% for FY2024, which is 768.00% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported FCF Margin of 25.87% as of FY2024, which was up 42.20% from 18.19% recorded in FY2023.
  • Supernus Pharmaceuticals' FCF Margin's 5-year high stood at 25.93% during FY2020, with a 5-year trough of 17.45% in FY2022.
  • Moreover, its 3-year median value for FCF Margin was 18.19% (2023), whereas its average is 20.50%.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by 981bps in 2020, then skyrocketed by 768bps in 2024.
  • Supernus Pharmaceuticals' FCF Margin (Yearly) stood at 25.93% in 2020, then tumbled by 401bps to 21.93% in 2021, then tumbled by 448bps to 17.45% in 2022, then surged by 75bps to 18.19% in 2023, then surged by 768bps to 25.87% in 2024.